MMDHD H1N1 Flu (Swine Flu) Information

For Providers and Clinicians

CDC Information For:

General H1N1 Info

Parents and Caregivers

Child Care Providers

Pregnant Women

Schools K-12

Colleges, and Universities

Travelers and Travel Industry

Clinicians

Lab Workers

Adults with HIV Infection

People with Cardiovascular Disease

People with Asthma

Deaf and Hard of Hearing

Businesses and Employers

Pharmacists

EMS and 911 Centers

Information for Providers and Clinicians

Vaccine Information Statements

H1N1 Vaccine Information Statement - Nasal Spray

H1N1 Vaccine Information Statement - Inactivated

H1N1 Vaccine Information Statement - Nasal Spray (Spanish)

H1N1 Vaccine Information Statement - Inactivated (Spanish)

Important Documents

Non-Safety-Related Voluntary Recall of Unused Doses from Certain Lots of Sanofi Pasteur H1N1 Vaccine in Pre-Filled Syringes (1-29-2010)

Updated Guidance for the Use of CSL™ 2009 H1N1 Monovalent Vaccine

CDC Current and Recent Key Messages (11-30-2009)

Revised CSL H1N1 vaccine indications and Usage: package insert (11-23-2009)

Fact Sheet on Live, Attenuated Influenza Vaccine (LAIV, intranasal) for Health Care Personnel (11-10-2009)

Key Issues for Clinicians Concerning Antiviral Treatments for 2009 H1N1 (11-6-2009)

CDC Recommendations for Early Empiric Antiviral Treatment (10-19-2009)

MDCH Update for Clinicians on the Reporting of Influenza-Associated Hospitalizations and Deaths

MDCH Vaccine Provider Agreement (9-21-2009)

MCIR Access Application for Providers (9-21-2009)

MMDHD Letter to Providers (9-18-2009)

MDCH Testing Guidelines (8-14-2009)

CDC/MDCH Important Links

Updated Interim Recommendations for the Use of Antiviral Medications in the Treatment and Prevention of Influenza for the 2009-2010 Season

Updated Interim Recommendations for the Use of Antiviral Medications in Pregnant Women

CDC Vaccine Target Populations

MDCH Laboratory Guidelines

FDA-Approved Antiviral Drugs for Influenza